BX Swiss TOP 30 CHF
|
1 412,53
|
10,43
|
0,74 %
|
Analysen zu BX Swiss TOP 30 CHF-Werten
| 10:52 | UBS Buy | Jefferies & Company Inc. | |
| 10:39 | UBS Outperform | RBC Capital Markets | |
| 10:32 | Novartis Neutral | UBS AG | |
| 09:54 | Givaudan Buy | Jefferies & Company Inc. | |
| 08:51 | Novartis Sell | Goldman Sachs Group Inc. | |
| 08:39 | UBS Underweight | Barclays Capital | |
| 08:14 | Novartis Hold | Jefferies & Company Inc. | |
| 08:13 | UBS Overweight | JP Morgan Chase & Co. | |
| 08:13 | UBS Buy | Goldman Sachs Group Inc. | |
| 02.02.26 | Roche Hold | Deutsche Bank AG | |
| 02.02.26 | ABB Sell | Deutsche Bank AG | |
| 02.02.26 | Roche Kaufen | DZ BANK | |
| 02.02.26 | Roche Underperform | Jefferies & Company Inc. | |
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | ABB Market-Perform | Bernstein Research | |
| 30.01.26 | Givaudan Neutral | UBS AG | |
| 30.01.26 | Roche Buy | UBS AG | |
| 30.01.26 | Swiss Re Underweight | Barclays Capital | |
| 30.01.26 | Roche Overweight | Barclays Capital | |
| 30.01.26 | Givaudan Overweight | Barclays Capital | |
| 30.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 30.01.26 | Givaudan Buy | Deutsche Bank AG | |
| 30.01.26 | ABB Underweight | Barclays Capital | |
| 30.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 30.01.26 | ABB Kaufen | DZ BANK | |
| 29.01.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 29.01.26 | Roche Outperform | Bernstein Research | |
| 29.01.26 | ABB Market-Perform | Bernstein Research | |
| 29.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | ABB Sector Perform | RBC Capital Markets | |
| 29.01.26 | ABB Neutral | UBS AG | |
| 29.01.26 | ABB Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Givaudan Neutral | UBS AG | |
| 29.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 29.01.26 | Roche Underperform | Jefferies & Company Inc. | |
| 29.01.26 | ABB Hold | Jefferies & Company Inc. | |
| 28.01.26 | Roche Hold | Deutsche Bank AG | |
| 27.01.26 | Roche Overweight | Barclays Capital | |
| 27.01.26 | Roche Underperform | Jefferies & Company Inc. |